PortfoliosLab logoPortfoliosLab logo
INMD vs. MEDP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INMD vs. MEDP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in InMode Ltd. (INMD) and Medpace Holdings, Inc. (MEDP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INMD achieves a -9.12% return, which is significantly higher than MEDP's -15.70% return.


INMD

1D
1.06%
1M
-2.84%
YTD
-9.12%
6M
-7.10%
1Y
-1.04%
3Y*
-28.14%
5Y*
-22.57%
10Y*

MEDP

1D
3.91%
1M
9.40%
YTD
-15.70%
6M
-16.89%
1Y
53.41%
3Y*
28.45%
5Y*
21.62%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

INMD vs. MEDP - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
INMD
InMode Ltd.
-9.12%-12.04%-24.91%-37.70%-49.42%197.30%21.12%187.71%
MEDP
Medpace Holdings, Inc.
-15.70%69.05%8.38%44.31%-2.40%56.35%65.60%10.26%

Correlation

The correlation between INMD and MEDP is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.39

Correlation (3Y)
Calculated over the trailing 3-year period

0.36

Correlation (5Y)
Calculated over the trailing 5-year period

0.45

Correlation (All Time)
Calculated using the full available price history since Aug 8, 2019

0.41

Fundamentals

Market Cap

INMD:

$853.63M

MEDP:

$13.71B

EPS

INMD:

$1.36

MEDP:

$15.63

PE Ratio

INMD:

9.78

MEDP:

30.29

PS Ratio

INMD:

2.28

MEDP:

5.21

PB Ratio

INMD:

1.29

MEDP:

22.92

Total Revenue (TTM)

INMD:

$374.64M

MEDP:

$2.68B

Gross Profit (TTM)

INMD:

$291.61M

MEDP:

$778.59M

EBITDA (TTM)

INMD:

$98.61M

MEDP:

$572.96M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INMD vs. MEDP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INMD
INMD Risk / Return Rank: 3939
Overall Rank
INMD Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
INMD Sortino Ratio Rank: 3636
Sortino Ratio Rank
INMD Omega Ratio Rank: 3636
Omega Ratio Rank
INMD Calmar Ratio Rank: 4141
Calmar Ratio Rank
INMD Martin Ratio Rank: 4141
Martin Ratio Rank

MEDP
MEDP Risk / Return Rank: 7272
Overall Rank
MEDP Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
MEDP Sortino Ratio Rank: 7373
Sortino Ratio Rank
MEDP Omega Ratio Rank: 8282
Omega Ratio Rank
MEDP Calmar Ratio Rank: 6969
Calmar Ratio Rank
MEDP Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INMD vs. MEDP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for InMode Ltd. (INMD) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


INMDMEDPDifference
Sharpe ratioReturn per unit of total volatility

-0.81

Sortino ratioReturn per unit of downside risk

-1.64

Omega ratioGain probability vs. loss probability

1.02

1.31

-0.29

Calmar ratioReturn relative to maximum drawdown

-0.04

1.47

-1.51

Martin ratioReturn relative to average drawdown

-0.09

3.17

-3.26

INMD vs. MEDP - Sharpe Ratio Comparison

The current INMD Sharpe Ratio is -0.03, which is lower than the MEDP Sharpe Ratio of 0.78. The chart below compares the historical Sharpe Ratios of INMD and MEDP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

INMD vs. MEDP - Drawdown Comparison

The maximum INMD drawdown since its inception was -86.96%, which is greater than MEDP's maximum drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for INMD and MEDP.


Loading charts...

Drawdown Indicators


INMDMEDPDifference

Max Drawdown

Largest peak-to-trough decline

-86.96%

-42.87%

-44.09%

Max Drawdown (1Y)

Largest decline over 1 year

-23.23%

-36.61%

+13.38%

Max Drawdown (3Y)

Largest decline over 3 years

-72.28%

-39.38%

-32.90%

Max Drawdown (5Y)

Largest decline over 5 years

-86.96%

-42.87%

-44.09%

Current Drawdown

Current decline from peak

-86.36%

-23.70%

-62.66%

Average Drawdown

Average peak-to-trough decline

-56.16%

-12.95%

-43.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.77%

16.91%

-5.14%

Volatility

INMD vs. MEDP - Volatility Comparison

The current volatility for InMode Ltd. (INMD) is 4.32%, while Medpace Holdings, Inc. (MEDP) has a volatility of 7.65%. This indicates that INMD experiences smaller price fluctuations and is considered to be less risky than MEDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INMDMEDPDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.32%

7.65%

-3.33%

Volatility (6M)

Calculated over the trailing 6-month period

25.28%

37.99%

-12.71%

Volatility (1Y)

Calculated over the trailing 1-year period

32.62%

69.04%

-36.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

52.15%

51.60%

+0.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.73%

49.72%

+11.01%

Dividends

INMD vs. MEDP - Dividend Comparison

Neither INMD nor MEDP has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

INMD vs. MEDP - Financials Comparison

This section allows you to compare key financial metrics between InMode Ltd. and Medpace Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M600.00M700.00M20222023202420252026
82.02M
706.60M
(INMD) Total Revenue
(MEDP) Total Revenue
Values in USD except per share items

INMD vs. MEDP - Profitability Comparison

The chart below illustrates the profitability comparison between InMode Ltd. and Medpace Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
75.1%
27.8%
Portfolio components
INMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, InMode Ltd. reported a gross profit of 61.55M and revenue of 82.02M. Therefore, the gross margin over that period was 75.1%.

MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a gross profit of 196.33M and revenue of 706.60M. Therefore, the gross margin over that period was 27.8%.

INMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, InMode Ltd. reported an operating income of 10.06M and revenue of 82.02M, resulting in an operating margin of 12.3%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported an operating income of 141.50M and revenue of 706.60M, resulting in an operating margin of 20.0%.

INMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, InMode Ltd. reported a net income of 11.56M and revenue of 82.02M, resulting in a net margin of 14.1%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a net income of 123.87M and revenue of 706.60M, resulting in a net margin of 17.5%.


Frequently Asked Questions


INMD and MEDP have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MEDP has higher volatility (7.65%) compared to INMD (4.32%). In terms of maximum drawdown, INMD dropped -86.96% vs MEDP's -42.87%.

MEDP currently has the higher Sharpe Ratio (0.78 vs -0.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INMD and MEDP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer